BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 8080389)

  • 1. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
    Henderson VW; Paganini-Hill A; Emanuel CK; Dunn ME; Buckwalter JG
    Arch Neurol; 1994 Sep; 51(9):896-900. PubMed ID: 8080389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
    Mulnard RA; Cotman CW; Kawas C; van Dyck CH; Sano M; Doody R; Koss E; Pfeiffer E; Jin S; Gamst A; Grundman M; Thomas R; Thal LJ
    JAMA; 2000 Feb; 283(8):1007-15. PubMed ID: 10697060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences on a brief measure of cognitive functioning in Alzheimer's disease.
    Buckwalter JG; Sobel E; Dunn ME; Diz MM; Henderson VW
    Arch Neurol; 1993 Jul; 50(7):757-60. PubMed ID: 8323481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender comparisons of cognitive performances among vascular dementia, Alzheimer disease, and older adults without dementia.
    Buckwalter JG; Rizzo AA; McCleary R; Shankle R; Dick M; Henderson VW
    Arch Neurol; 1996 May; 53(5):436-9. PubMed ID: 8624219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy to maintain cognitive function in women with dementia.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease.
    Henderson VW; Watt L; Buckwalter JG
    Psychoneuroendocrinology; 1996 May; 21(4):421-30. PubMed ID: 8844880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between mood and estradiol (E2) levels in Alzheimer's disease (AD) patients.
    Carlson LE; Sherwin BB; Chertkow HM
    J Gerontol B Psychol Sci Soc Sci; 2000 Jan; 55(1):P47-53. PubMed ID: 10728123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive deficits of men and women with Alzheimer's disease.
    Henderson VW; Buckwalter JG
    Neurology; 1994 Jan; 44(1):90-6. PubMed ID: 8290098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement therapy and risk of Alzheimer disease.
    Paganini-Hill A; Henderson VW
    Arch Intern Med; 1996 Oct; 156(19):2213-7. PubMed ID: 8885820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.
    Wang PN; Liao SQ; Liu RS; Liu CY; Chao HT; Lu SR; Yu HY; Wang SJ; Liu HC
    Neurology; 2000 Jun; 54(11):2061-6. PubMed ID: 10851363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial.
    Henderson VW; Paganini-Hill A; Miller BL; Elble RJ; Reyes PF; Shoupe D; McCleary CA; Klein RA; Hake AM; Farlow MR
    Neurology; 2000 Jan; 54(2):295-301. PubMed ID: 10668686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women.
    Manly JJ; Merchant CA; Jacobs DM; Small SA; Bell K; Ferin M; Mayeux R
    Neurology; 2000 Feb; 54(4):833-7. PubMed ID: 10690972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood symptoms and cognitive performance in women estrogen users and nonusers and men.
    Miller KJ; Conney JC; Rasgon NL; Fairbanks LA; Small GW
    J Am Geriatr Soc; 2002 Nov; 50(11):1826-30. PubMed ID: 12410901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men.
    Lu PH; Masterman DA; Mulnard R; Cotman C; Miller B; Yaffe K; Reback E; Porter V; Swerdloff R; Cummings JL
    Arch Neurol; 2006 Feb; 63(2):177-85. PubMed ID: 16344336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.
    Baldereschi M; Di Carlo A; Lepore V; Bracco L; Maggi S; Grigoletto F; Scarlato G; Amaducci L
    Neurology; 1998 Apr; 50(4):996-1002. PubMed ID: 9566385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease.
    Schneider LS; Farlow MR; Henderson VW; Pogoda JM
    Neurology; 1996 Jun; 46(6):1580-4. PubMed ID: 8649552
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.